48 completed. 48 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 48 | Completed 48 |
Follow Tetanus: new trials by email Literature Review of Tetanus trials Research Report on Tetanus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PFAS Exposure and Immune Response to Vaccination in Adults TENIVAC - Innate Inflammatory Response, Vaccination | Phase 4 | Completed | Rutgers, The State University of New Jersey | 20 | 2024-11-04 | 2025-12-30 |
| A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers DTPa-HBV-IPV/Hib, DTaP5-HBV-IPV-Hib, Pneumococcal 13-valent conjugate vaccine - Diphtheria | Phase 4 | Completed | GlaxoSmithKline | 500 | 2021-05-26 | 2024-08-27 |
| Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Infanrix hexa - Diphtheria, Hepatitis B | Phase 4 | Completed | GlaxoSmithKline | 551 | 2016-09-19 | 2020-01-14 |
| Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants Squarekids, Rotarix - Rotavirus | Phase 4 | Completed | GlaxoSmithKline | 292 | 2016-09-16 | 2019-11-25 |
| Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Infanrix hexa, Prevnar13 - Acellular Pertussis, Tetanus | Phase 4 | Completed | GlaxoSmithKline | 601 | 2016-01-22 | 2019-07-09 |
| A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays Menveo®, Boostrix®, Pneumovax 23® - Meningococcal | Phase 4 | Completed | GlaxoSmithKline | 359 | 2014-04-01 | 2017-11-27 |
| Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine Tetanus-diphtheria (Td) and PCV13, PCV13 alone, Td alone - Tetanus, Diphtheria | Phase 4 | Completed | Korea University Guro Hospital | 462 | 2013-11-01 | 2018-06-11 |
| Hepatitis B Vaccination in Infants Menjugate, Menitorix, NeisVac-C - Meningococcal Disease, Pneumococcal Disease | Phase 4 | Completed | Public Health England | 300 | 2013-07-01 | 2020-10-01 |
| Tdap Vaccine in Post-Partum Women Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed onto aluminum phosphate - Diphtheria, Pertussis | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 55 | 2012-10-26 | 2017-05-05 |
| Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age Meningococcal polysaccharide diphtheria toxoid conjugate, Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate - Meningitis, Meningococcal Infection | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 1394 | 2012-07-01 | 2015-12-15 |
| Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®), Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®) - Tetanus, Diphtheria | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 423 | 2012-06-01 | 2016-03-02 |
| Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE Diphtheria, tetanus, polio and pertussis vaccination - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 278 | 2012-02-01 | 2017-09-11 |
| Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China DTacP IPV//PRP~T combined vaccine: PENTAXIM® - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 900 | 2011-12-01 | 2013-03-29 |
| Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine, Tetanus and Diphtheria Toxoids Adsorbed For Adult Use - Tetanus, Diphtheria | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 1330 | 2011-11-01 | 2022-04-28 |
| A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents Placebo + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine, MenACWY-CRM Conjugate Vaccine + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine - Meningococcal Meningitis | Phase 4 | Completed | Novartis | 801 | 2011-09-01 | 2014-02-14 |
| Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents Boostrix TM (new syringe presentation), Boostrix TM (previous syringe presentation) - Diphtheria, Tetanus | Phase 4 | Completed | GlaxoSmithKline | 671 | 2011-07-01 | 2018-08-10 |
| Regulatory Post-Marketing Surveillance Study for TETRAXIM™ TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 600 | 2011-06-01 | 2022-03-28 |
| Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ Blood Sampling - Tetanus, Poliomyelitis | Phase 4 | Completed | GlaxoSmithKline | 58 | 2011-05-30 | 2021-01-19 |
| Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination Quinvaxem, Quinvaxem/Tritanrix - Diphtheria, Pertussis | Phase 4 | Completed | Crucell Holland BV | 400 | 2011-05-01 | 2013-09-09 |
| Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults BoostrixTM Polio - Acellular Pertussis, Poliomyelitis | Phase 4 | Completed | GlaxoSmithKline | 212 | 2011-04-01 | 2018-06-06 |
Showing 20 of 48. Sign in to see all of them.
Diphtheria (47) · Whooping Cough (32) · Poliomyelitis (19) · Haemophilus Infections (13) · Hepatitis B (10) · Meningitis (3) · Meningococcal Infections (3) · Pneumococcal Infections (2) · Infant Death (1) · Inflammation (1) · Measles (1) · Meningitis, Meningococcal (1) · Virus Diseases (1)
Bacterial Infections (48) · Bacterial Infections and Mycoses (48) · Clostridium Infections (48) · Gram-Positive Bacterial Infections (48) · Infections (48) · Actinomycetales Infections (47) · Corynebacterium Infections (47) · Gram-Negative Bacterial Infections (37) · Bordetella Infections (32) · Respiratory Tract Diseases (32) · Respiratory Tract Infections (32) · Virus Diseases (24) · Nervous System Diseases (22) · Neuroinflammatory Diseases (22) · Central Nervous System Diseases (20)
Tetanus Toxoid (14) · adacel (10) · Boostrix (7) · Diphtheria-Tetanus Vaccine (4) · Meningococcal Vaccines (4) · Pentavac (3) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (3) · 13-valent pneumococcal vaccine (2) · Poliovirus Vaccine, Inactivated (2) · Vaccines (2) · 23-valent pneumococcal capsular polysaccharide vaccine (1) · Blood Specimen Collection (1) · Diphtheria Toxoid (1) · Diphtheria-Tetanus-acellular Pertussis Vaccines (1) · Hexavac (1)
GlaxoSmithKline (19) · Sanofi Pasteur, a Sanofi Company (13) · Sanofi (6) · Shantha Biotechnics Limited (2) · Bandim Health Project (1) · Crucell Holland BV (1) · Korea University Guro Hospital (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Norwegian Institute of Public Health (1) · Novartis (1) · Public Health England (1) · Rutgers, The State University of New Jersey (1)
United States (14) · Canada (7) · Italy (5) · Finland (4) · Germany (4) · Spain (4) · Australia (3) · Belgium (2) · Czechia (2) · France (2) · India (2) · Norway (2) · Philippines (2) · Russia (2) · South Korea (2)
Raman Rao, MD (2) · Elizabeth Coates, PhD (1) · Maria RZ Capeding, MD (1) · Robert Laumbach, MD (1) · Synne Sandbu, Physician (1)
PMID 20448468, PMID 20616762, PMID 21134450, PMID 22115634, PMID 23077849, PMID 24176498, PMID 24835247, PMID 25230939, PMID 25613716, PMID 25882172, PMID 26075317, PMID 29438562, PMID 29573876, PMID 30518331, PMID 31301919, PMID 31377946, PMID 31776027, PMID 33612341, PMID 35575974
2014 (3), 2015 (1), 2019 (1)